BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25228074)

  • 1. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X; Xie P; Liu J; Wu H; Xie Y
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
    Yuan Y; He W; Yang Z; Qiu J; Huang Z; Shi Y; Lin Z; Zheng Y; Chen M; Lau WY; Li B; Yuan Y
    Int J Surg; 2023 May; 109(5):1222-1230. PubMed ID: 37026861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential transcatheter arterial chemoembolization and portal vein embolization before hepatectomy for the management of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Liao Y; Cai Q; Zhang X; Li F
    Updates Surg; 2023 Oct; 75(7):1741-1750. PubMed ID: 37428411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization.
    Luo X; Chang RZ; Kuang D; Yuan M; Li GX; Zhang B; Wang YJ; Zhang WG; Ding ZY
    Front Immunol; 2023; 14():1285296. PubMed ID: 37928536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma.
    Hong D; Zhou Y; Wan X; Su H; Shao H
    BMC Cancer; 2021 Sep; 21(1):1020. PubMed ID: 34521375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
    Yuan L; Feng J; Zhang Y; Lu C; Xu L; Liang C; Liu Z; Mao F; Xiang Y; Wang W; Wang K; Cheng S
    Eur J Surg Oncol; 2023 Jul; 49(7):1226-1233. PubMed ID: 36739252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus.
    Wu HX; Ding XY; Xu YW; Yu MH; Li XM; Deng N; Chen JL
    World J Gastroenterol; 2024 Feb; 30(8):843-854. PubMed ID: 38516240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Eur Radiol; 2023 Dec; 33(12):8715-8726. PubMed ID: 37436507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jiedu Granule Combined with Transcatheter Arterial Chemoembolization and Gamma Knife Radiosurgery in Treating Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Wang J; Luo J; Yin X; Huang W; Cao H; Wang G; Wang J; Zhou J
    Biomed Res Int; 2019; 2019():4696843. PubMed ID: 31341898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
    Lu J; Guo JH; Ji JS; Li YL; Lv WF; Zhu HD; Sun JH; Ren WX; Zhang FJ; Wang WD; Shao HB; Cao GS; Li HL; Gao K; Yang P; Yin GW; Zhu GY; Wu FZ; Wang WJ; Lu D; Chen SQ; Min J; Zhao Y; Li R; Lu LG; Lau WY; Teng GJ
    Int J Surg; 2023 May; 109(5):1188-1198. PubMed ID: 37038986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis.
    Deng J; Liao Z; Gao J
    Curr Oncol; 2023 Jan; 30(1):1243-1254. PubMed ID: 36661745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
    Hwang H; Kim JH; Ko E; Kim JY; Ko HK; Gwon DI; Shin JH; Kim GH; Chu HH
    Br J Radiol; 2024 May; 97(1157):1038-1043. PubMed ID: 38445658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.
    Vogl TJ; Nour-Eldin NE; Emad-Eldin S; Naguib NN; Trojan J; Ackermann H; Abdelaziz O
    World J Gastroenterol; 2011 Mar; 17(10):1267-75. PubMed ID: 21455325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review.
    Shao Z; Liu X; Peng C; Wang L; Xu D
    World J Surg Oncol; 2021 Oct; 19(1):293. PubMed ID: 34598689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.
    Minagawa M; Makuuchi M
    World J Gastroenterol; 2006 Dec; 12(47):7561-7. PubMed ID: 17171782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ALPPS still appropriate for large or locally advanced hepatocellular carcinoma in an era of targeted agents and immunotherapy?
    Lu YX; Zhao JP; Zhang WG
    Updates Surg; 2024 Jun; 76(3):899-910. PubMed ID: 38526694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus.
    Tan ZB; Zhang J
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8119-8134. PubMed ID: 37750640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
    Komatsu S; Ueshima K; Kido M; Kuramitsu K; Tsugawa D; Yanagimoto H; Toyama H; Ku Y; Kudo M; Fukumoto T
    J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):303-314. PubMed ID: 36047804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives.
    Gavriilidis P; Pawlik TM; Azoulay D
    Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):221-227. PubMed ID: 37903712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Wu DH; Liu L; Chen LH
    World J Gastroenterol; 2004 Aug; 10(15):2184-9. PubMed ID: 15259062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.